▼ SELL
$ Value
$71K
Shares
19,000
Price
$4
Filed
Aug 20
Insider
Name
Ferguson Toby
Title
Chief Medical Officer
CIK
0002015616
Roles
Officer
Transaction Details
Transaction Date
2025-08-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
138,914
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Filing Info
Ferguson Toby's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-06 | VYGR | A | $0 |
| 2026-02-06 | VYGR | A | $0 |
| 2025-08-18 | VYGR | ▼ | $71K |
Other Insiders at VYGR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sandrock Alfred
President and CEO
|
— | $184K | 2026-04-02 |
|
Jorgensen Nathan D.
Chief Financial Officer
|
— | $18K | 2026-02-24 |
|
Swartz Robin
COO & CBO
|
— | $55K | 2026-02-24 |
|
Carter Todd Alfred
Chief Scientific Officer
|
— | $41K | 2026-02-24 |
|
Ferguson Toby
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Shiferman Gregory L.
SVP and General Counsel
|
— | — | 2026-04-01 |